Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![TorontoStar Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::12848262.png) Toronto Star [@TorontoStar](/creator/twitter/TorontoStar) on x 1.2M followers
Created: 2025-07-08 00:03:06 UTC

A breakthrough drug could slow Alzheimer’s. 

Health Canada is currently evaluating two drugs — lecanemab and donanemab — that may slow the progression of Alzheimer’s in some patients with mild disease.

![](https://pbs.twimg.com/card_img/1941845426346278912/rYpo0Jmb?format=jpg&name=600x314)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1942373841797366247/c:line.svg)

**Related Topics**
[drugs](/topic/drugs)
[canada](/topic/canada)
[breakthrough](/topic/breakthrough)
[toronto](/topic/toronto)

[Post Link](https://x.com/TorontoStar/status/1942373841797366247)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

TorontoStar Avatar Toronto Star @TorontoStar on x 1.2M followers Created: 2025-07-08 00:03:06 UTC

A breakthrough drug could slow Alzheimer’s.

Health Canada is currently evaluating two drugs — lecanemab and donanemab — that may slow the progression of Alzheimer’s in some patients with mild disease.

XXXXX engagements

Engagements Line Chart

Related Topics drugs canada breakthrough toronto

Post Link

post/tweet::1942373841797366247
/post/tweet::1942373841797366247